Subject(s)

Antineoplastic Agents/therapeutic use , Gamma Rays/therapeutic use , Hodgkin Disease/therapy , Lymphopoiesis/radiation effects , Thymus Gland/radiation effects , Adult , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , B-Lymphocytes/pathology , B-Lymphocytes/radiation effects , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/pathology , CD4-Positive T-Lymphocytes/radiation effects , CD8-Positive T-Lymphocytes/drug effects , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/radiation effects , Female , Hodgkin Disease/immunology , Hodgkin Disease/pathology , Humans , Immunophenotyping , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Killer Cells, Natural/pathology , Killer Cells, Natural/radiation effects , Lymphopoiesis/drug effects , Lymphopoiesis/immunology , Male , Middle Aged , Neoplasm Staging , Prospective Studies , Thymus Gland/drug effects , Thymus Gland/immunology , Thymus Gland/pathology